Main Page  »  Research  »  Drug Trials
« Previous  |  Next »
Monday, January 21
View Article  Trial – for efficacy and safety of FTY720
by multiplesclerosis on Mon 21 Jan 2008 12:00 AM CST

Trial – for efficacy and safety of FTY720

 

Trial Information

Summary: A 24-month, double-blind, randomized, multi-center, placebo-controlled, parallel-group study comparing the efficacy and safety ...   more »

Leave Comment  |  Permanent Link  |  Cosmos
Saturday, January 19
View Article  Trial for MS patients with Cognitive Impairment
by multiplesclerosis on Sat 19 Jan 2008 12:00 AM CST

Trial for MS patients with Cognitive Impairment

 

Trial Information

Summary: A Randomized, Double-Blind, Placebo-Controlled, Dose Titration Study to Assess the Safety, Efficacy and Tolerability ...   more »

Leave Comment  |  Permanent Link  |  Cosmos
Friday, January 18
View Article  Trial – Fampridine-SR (can it improve walking ability and muscle strength in MS?)
by multiplesclerosis on Fri 18 Jan 2008 08:42 AM CST

Trial – Fampridine-SR (can it improve walking ability and muscle strength in MS?)

 

Trial Information

Summary: A 21 WEEK STUDY TO EVALUATE SAFETY AND ...   more »

Leave Comment  |  Permanent Link  |  Cosmos
View Article  Rebif-New Formulation Drug Trial for RRMS
by multiplesclerosis on Fri 18 Jan 2008 08:17 AM CST

Rebif-New Formulation Drug Trial for RRMS

 

Trial Information

Summary: Quality of Life study for patients with relapsing forms of Multiple Sclerosis who are transitioning ...   more »

Leave Comment  |  Permanent Link  |  Cosmos
Wednesday, January 16
View Article  clinical trial - California
by multiplesclerosis on Wed 16 Jan 2008 08:10 AM CST

Summary: Have you been diagnosed with Multiple Sclerosis?

Novartis Pharmaceuticals Corporation is conducting a clinical research study to find out if an oral once-a-day investigational ...   more »

Leave Comment  |  Permanent Link  |  Cosmos
View Article  Clinical Trial Sweden
by multiplesclerosis on Wed 16 Jan 2008 08:02 AM CST

Trial Information

Summary: Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

The objective of ...   more »

Leave Comment  |  Permanent Link  |  Cosmos
Monday, January 7
View Article  OFATUMUMAB PHASE II STUDY IN MULTIPLE SCLEROSIS
by multiplesclerosis on Mon 07 Jan 2008 12:00 AM CST

GENMAB ANNOUNCES DETAILS OF PLANNED OFATUMUMAB PHASE II STUDY IN MULTIPLE SCLEROSIS

 

Copenhagen, Denmark

 

December 13, 2007 –

Genmab A/S (OMX: GEN) announced ...   more »

Leave Comment  |  Permanent Link  |  Cosmos
Sunday, January 6
View Article  Trial with Tovaxin™ for Multiple Sclerosis
by multiplesclerosis on Sun 06 Jan 2008 12:00 AM CST

Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin™ for Multiple Sclerosis

 

Effectiveness Shown in Relapsing Remitting Subjects Across Both ...   more »

Leave Comment  |  Permanent Link  |  Cosmos
Wednesday, January 2
View Article  Daclizumab Reduces Brain Lesions
by multiplesclerosis on Wed 02 Jan 2008 12:00 AM CST

Daclizumab Reduces Brain Lesions in Patients With Active, Relapsing Multiple Sclerosis on Interferon-Beta Therapy

 

 

PRAGUE, CZECH REPUBLIC

 

The addition of the humanized ...   more »

Leave Comment  |  Permanent Link  |  Cosmos
Tuesday, January 1
View Article  Large Trial Of Oral Antibiotic Minocycline Set To Begin In People At Risk For MS
by multiplesclerosis on Tue 01 Jan 2008 05:00 PM CST

Large Trial Of Oral Antibiotic Minocycline Set To Begin In People At Risk For MS


Exciting news of the launch of a Canada-wide clinical trial ...   more »

Leave Comment  |  Permanent Link  |  Cosmos